Updated On: 13 June, 2021 08:30 AM IST | Ottawa | Agencies
To ensure the safety of any future vaccine supply from this facility, Health Canada is planning an on-site inspection, expected to take place later this year

A man receives a dose of Johnson & Johnson vaccine at Miami International Airport, in Miami. Pic/AFP
The state-run Health Canada said that it will not use the 3,00,000 Johnson & Johnson Covid-19 vaccine doses, which arrived in the country in April due to a possible quality issue.
“To protect the health and safety of Canadians in response to concerns regarding a drug substance produced at the Emergent BioSolutions facility in Baltimore Maryland, Health Canada will not be releasing the shipment,” the government department said in a statement on Friday.